尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Guest Kevin, 首席执行官. Officer active across 1 company, notably Usana Health Sciences INC. In total, 16 reports have been recorded. Split: 0 buy · 4 sells. Total volume traded: €887k. Activity tracked since 4 November 2021. The latest transaction was disclosed on 11 March 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 条申报中的 16 条
Guest Kevin is Directeur Général at Usana Health Sciences INC, where his listed function is CEO & EXEC. CHAIRMAN OF BOARD. He has 16 filings in total, and across the sampled recent filings from 2021-10-26 to 2026-03-03, the reported transactions are sells totaling EUR 886577, with Levée d'options as the most frequent transaction nature.